CORE ENTREE II VALVE/REDUCER CD775

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 2005-05-21 for CORE ENTREE II VALVE/REDUCER CD775 manufactured by Conmed Corp..

Event Text Entries

[389298] "during a lap procedure, the inner nual separated from the valve and fell into the surgical site. It was retrieved. No patient injury was reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1317214-2005-00055
MDR Report Key606517
Report Source05,06
Date Received2005-05-21
Date of Event2005-04-11
Date Mfgr Received2005-04-12
Device Manufacturer Date2004-11-01
Date Added to Maude2005-05-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactNANCY CRISINO, SUPERVISOR
Manufacturer Street525 FRENCH ROAD
Manufacturer CityUTICA NY 13502
Manufacturer CountryUS
Manufacturer Postal13502
Manufacturer Phone3156243078
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCORE ENTREE II VALVE/REDUCER
Generic NameLAP CANNULA SYSTEM
Product CodeFBM
Date Received2005-05-21
Returned To Mfg2005-04-14
Model NumberNA
Catalog NumberCD775
Lot Number0411291
ID NumberNA
Device Expiration Date2009-11-01
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device Eval'ed by MfgrY
Implant FlagN
Date Removed*
Device Sequence No1
Device Event Key596299
ManufacturerCONMED CORP.
Manufacturer Address* UTICA NY * US
Baseline Brand NameCORE ENTREE II VALVE/REDUCER
Baseline Generic NameENDO VALVE REDUCER
Baseline Model NoNA
Baseline Catalog NoCD775
Baseline IDNA
Baseline Device FamilyENDOSCOPIC TROCAR/CANNULA SYSTEMS
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]60
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK911813
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
10 2005-05-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.